WallStreetZenWallStreetZen

NYSEMKT: STXS
Stereotaxis Inc Stock

$1.68-0.10 (-5.62%)
Updated Sep 22, 2023
STXS Price
$1.68
Fair Value Price
N/A
Market Cap
$135.86M
52 Week Low
$1.33
52 Week High
$2.75
P/E
-6.22x
P/B
6.35x
P/S
4.22x
PEG
N/A
Dividend Yield
N/A
Revenue
$29.37M
Earnings
-$19.38M
Gross Margin
57.7%
Operating Margin
-67.47%
Profit Margin
-70.6%
Debt to Equity
1
Operating Cash Flow
-$11M
Beta
0.92
Next Earnings
Nov 8, 2023
Ex-Dividend
N/A
Next Dividend
N/A

STXS Overview

Stereotaxis Incorporated manufactures and sells robotic systems, instruments, and information system for the interventional laboratory sector in the U.S. and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe, which enable physicians to complete complex procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company also offers Vdrive, a system that offers navigation and stability for diagnostic and therapeutic devices. Stereotaxis was incorporated in 1990 and is headquartered in Saint Louis, MO.

Zen Score

Industry Average (32)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how STXS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

STXS is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
STXS is poor value based on its book value relative to its share price (6.35x), compared to the US Medical Instruments & Supplies industry average (3.36x)
P/B vs Industry Valuation
STXS is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more STXS due diligence checks available for Premium users.

Be the first to know about important STXS news, forecast changes, insider trades & much more!

Valuation

STXS price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-6.22x
Industry
49.7x
Market
14.52x

STXS price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
6.35x
Industry
3.36x
STXS is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

STXS's financial health

Profit margin

Revenue
$7.9M
Net Income
-$5.0M
Profit Margin
-67.3%
STXS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
STXS's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$48.3M
Liabilities
$21.3M
Debt to equity
1
STXS's short-term assets ($38.90M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
STXS's short-term assets ($38.90M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
STXS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
STXS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.9M
Investing
$20.1M
Financing
-$26.0k
STXS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

STXS vs Medical Stocks

TickerMarket Cap1d %P/EP/B
STXS$135.86M-5.62%-6.22x6.35x
KRMD$127.79M-3.95%-16.47x4.55x
ZTEK$125.68M-1.41%-7.56x5.90x
ZJYL$150.24M+17.01%N/A6.38x
BNGO$103.22M-2.01%-0.60x0.48x

Stereotaxis Stock FAQ

What is Stereotaxis's quote symbol?

(NYSEMKT: STXS) Stereotaxis trades on the NYSEMKT under the ticker symbol STXS. Stereotaxis stock quotes can also be displayed as NYSEMKT: STXS.

If you're new to stock investing, here's how to buy Stereotaxis stock.

What is the 52 week high and low for Stereotaxis (NYSEMKT: STXS)?

(NYSEMKT: STXS) Stereotaxis's 52-week high was $2.75, and its 52-week low was $1.33. It is currently -38.8% from its 52-week high and 26.32% from its 52-week low.

How much is Stereotaxis stock worth today?

(NYSEMKT: STXS) Stereotaxis currently has 80,868,280 outstanding shares. With Stereotaxis stock trading at $1.68 per share, the total value of Stereotaxis stock (market capitalization) is $135.86M.

Stereotaxis stock was originally listed at a price of $71.35 in Aug 12, 2004. If you had invested in Stereotaxis stock at $71.35, your return over the last 19 years would have been -97.65%, for an annualized return of -17.91% (not including any dividends or dividend reinvestments).

How much is Stereotaxis's stock price per share?

(NYSEMKT: STXS) Stereotaxis stock price per share is $1.68 today (as of Sep 22, 2023).

What is Stereotaxis's Market Cap?

(NYSEMKT: STXS) Stereotaxis's market cap is $135.86M, as of Sep 24, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Stereotaxis's market cap is calculated by multiplying STXS's current stock price of $1.68 by STXS's total outstanding shares of 80,868,280.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.